Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington’s disease
Abstract Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease caused by an abnormal expansion of cytosine-adenine-guanosine (CAG) trinucleotidein the huntingtin gene. Mutant huntingtin (mHTT) expression in neurons and glial cells affects neuron and astrocyte functions and lea...
| Published in: | Acta Neuropathologica Communications |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40478-025-02054-4 |
